Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma

Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma

Jing Li,1 Peng Li,2 Hong Su,1 Haonan Feng,3 Zhongyuan Bai,4 Yanfeng Xi1 1Department of Pathology, Cancer Hospital Affiliated to Shanxi Medical University, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, Shanxi, 030013, Peo...

Full description

Bibliographic Details
Main Authors:	Li J, Li P, Su H, Feng H, Bai Z, Xi Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	International Journal of General Medicine
Subjects:	cyclin-dependent protein kinase 6 diffuse large b-cell lymphoma bioinformatics analysis prognosis
Online Access:	https://www.dovepress.com/expression-and-significance-of-cyclin-dependent-protein-kinase-6-in-di-peer-reviewed-fulltext-article-IJGM

Similar Items

Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells
by: Liling Jiang, et al.
Published: (2022-12-01)

Cyclin-dependent kinase inhibitors: efficacy and safety
by: I. B. Kononenko, et al.
Published: (2019-06-01)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
by: Zhong-liu Wei, et al.
Published: (2022-02-01)

Correlation of serum concentration cyclin-dependent kinase 4 and cyclin-dependent kinase 6 with breast cancer in Babylon province
by: Dalya Shakir Al-Owaidi, et al.
Published: (2020-01-01)

A review on the role of cyclin dependent kinases in cancers
by: Soudeh Ghafouri-Fard, et al.
Published: (2022-10-01)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711, et al.
Published: (2018)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711
Published: (2018)

Expression of cyclooxygenase-2(COX-2) and cyclin dependent kinase 1B (CDKN1B/p27Kip1⁯) in human prostatet adenocarcinoma
by: Md Roduan, Mohd Rohaizad
Published: (2011)

Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases
by: Mark Klein
Published: (2023-03-01)

Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation
by: Yean Huang, et al.
Published: (2022-08-01)

Identification of abemaciclib derivatives targeting cyclin-dependent kinase 4 and 6 using molecular dynamics, binding free energy calculation, synthesis, and pharmacological evaluation
by: Yanting Zhou, et al.
Published: (2023-05-01)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
by: Xiaopeng Cai, et al.
Published: (2021-10-01)

Induction of apoptosis in cancer cells by tumor necrosis factor and butyrolactone, an inhibitor of cyclin-dependent kinases
by: J.E. Belizário, et al.
Published: (1999-04-01)

Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
by: Atakan TEKİNALP, et al.
Published: (2020-12-01)

A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
by: Hao Huang, et al.
Published: (2023-07-01)

Flowcytometric evaluation of cell cycle regulators (cyclins and cyclin dependent kinase inhibitors) expressed on bone marrow cells of patients with chronic myelogenous leukemia and multiple myeloma
by: Selami Koçak Toprak, et al.
Published: (2012-03-01)

Cyclin B Export to the Cytoplasm via the Nup62 Subcomplex and Subsequent Rapid Nuclear Import Are Required for the Initiation of <i>Drosophila</i> Male Meiosis
by: Kanta Yamazoe, et al.
Published: (2023-11-01)

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
by: Ting-Xun Lu, et al.
Published: (2019-06-01)

Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs)
by: Ali Hassanzadeh, et al.
Published: (2024-06-01)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
by: Wenting Huang, et al.
Published: (2017-12-01)

Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data
by: Marcin Kubeczko, et al.
Published: (2024-07-01)

CELL CYCLE REGULATOR: CYCLIN DEPENDENT KINASE 10 AS POTENTIAL TARGET IN CANCER
by: Muhammad Fazal Hussain Qureshi, et al.
Published: (2019-04-01)

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
by: Han‐Jie Zhang, et al.
Published: (2021-11-01)

ASSOCIATION OF RS2069502 CYCLIN-DEPENDENT KINASE 4 GENE WITH BREAST CANCER
by: Dalya Shakir Al-owaidi
Published: (2020-04-01)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
by: Kai Yu, et al.
Published: (2022-05-01)

Unveiling CKS2: A Key Player in Aggressive B‐Cell Lymphoma Progression and a Target for Synergistic Therapy
by: Fenling Zhou, et al.
Published: (2024-11-01)

Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer
by: Adewale Oluwaseun Fadaka, et al.
Published: (2021-03-01)

Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy
by: Ying Ni, et al.
Published: (2022-08-01)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-05-01)

Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome editing
by: Bo Min Park, et al.
Published: (2018-12-01)

A Functional Kinase Is Necessary for Cyclin-Dependent Kinase G1 (CDKG1) to Maintain Fertility at High Ambient Temperature in Arabidopsis
by: Candida Nibau, et al.
Published: (2020-11-01)

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
by: Hasan Çağrı Yıldırım, et al.
Published: (2022-12-01)

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
by: Diana Malarikova, et al.
Published: (2024-03-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer
by: L. Bender, et al.
Published: (2023-01-01)

Design, Synthesis, and Activity Assays of Cyclin-Dependent Kinase 1 Inhibitors With Flavone Scaffolds
by: Lanlan Fu, et al.
Published: (2022-08-01)

Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5
by: Xu Yang, et al.
Published: (2018-04-01)

Anaplastic lymphoma kinase–positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates
by: Shuku Sato, et al.
Published: (2020-10-01)

CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma
by: Mingfang Shen, et al.
Published: (2023-10-01)

A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmission
by: Aurélia C Balestra, et al.
Published: (2020-06-01)